Photo taken from ESMO/LinkedIn
Jun 29, 2024, 02:57
Komal Jhaveri on antibody-drug conjugates in metastatic breast cancer – ESMO
ESMO shared a post on LinkedIn:
“For European Society for Medical Oncology (ESMO) members: Breaking Science in Breast Cancer.
Komal Jhaveri talks about the efficacy and safety of antibody-drug conjugates in metastatic breast cancer.
Don’t miss this video and others from the series on OncologyPRO.
Additional information.
Source: ESMO/LinkedIn
Jun 30, 2024, 16:30
Jun 30, 2024, 16:23
Jun 30, 2024, 16:16
Jun 30, 2024, 15:14